Their Insulin and Sales
Código 293712 (Harmonized System 2012 by 6 digits)
2023: US$12.6M, International Purchases
Código 293712 (Harmonized System 2012 by 6 digits)
2023: US$12.6M, International Purchases
The visualizations show the net balance of Their Insulin and Sales at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Their Insulin and Sales and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Their Insulin and Sales. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Their Insulin and Sales. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Their Insulin and Sales were Denmark (US$1.38B), United States (US$873M), and Portugal (US$94.9M). In the same year, the main importing countries for Their Insulin and Sales were China (US$1.19B), Italy (US$503M), and France (US$369M).